Arrowhead Pharmaceuticals (ARWR) Return on Sales [ROS] (2010 - 2026)
Arrowhead Pharmaceuticals' Return on Sales [ROS] was -226.03% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 370.18 percentage points from -596.21% a year earlier but down 34.46 percentage points from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arrowhead Pharmaceuticals' Return on Sales [ROS] was -33.82% through Jun 30, 2026, down 14.98 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it was 11.86%, up 16938.92 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of +117.73 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Return on Sales [ROS] was -16927.06% in FY2024 (-16841.91 pp), -85.16% in FY2023 (-11.77 pp), -73.39% in FY2022 (+34.38 pp) and -107.77% in FY2021 (-1.90 pp).
- Quarterly Return on Sales [ROS] has moved between -16927.06% (fiscal Q4 2024) and 70.24% (fiscal Q2 2025) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of +1031.74 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was fiscal Q4 2025 (a gain of 16944.26 percentage points); the worst was fiscal Q4 2024 (a drop of 16254.08 percentage points).
- Per Business Quant data, ARWR's Return on Sales [ROS] in the three fiscal quarters before Q3 2026 was -191.57% (Q2 2026), 15.46% (Q1 2026) and 17.20% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - | -226.03% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -226.03% |
| Mar 31, 2026 | -191.57% |
| Dec 31, 2025 | 15.46% |
| Sep 30, 2025 | 17.20% |
| Jun 30, 2025 | -596.21% |
| Mar 31, 2025 | 70.24% |
| Dec 31, 2024 | -6,456.48% |
| Sep 30, 2024 | -16,927.06% |
| Jun 30, 2024 | -2,785.05% |
| Mar 31, 2024 | -1,335.58% |
| Dec 31, 2023 | -3,845.25% |
| Sep 30, 2023 | -672.98% |
| Jun 30, 2023 | -648.99% |
| Mar 31, 2023 | 32.93% |
| Dec 31, 2022 | -67.36% |
| Sep 30, 2022 | -265.49% |
| Jun 30, 2022 | -224.94% |
| Mar 31, 2022 | 27.37% |
| Dec 31, 2021 | -230.77% |
| Sep 30, 2021 | -169.48% |
Arrowhead Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();